pentetic acid has been researched along with Leukemia, Myelogenous, Chronic, BCR-ABL Positive in 2 studies
Pentetic Acid: An iron chelating agent with properties like EDETIC ACID. DTPA has also been used as a chelator for other metals, such as plutonium.
Leukemia, Myelogenous, Chronic, BCR-ABL Positive: Clonal hematopoetic disorder caused by an acquired genetic defect in PLURIPOTENT STEM CELLS. It starts in MYELOID CELLS of the bone marrow, invades the blood and then other organs. The condition progresses from a stable, more indolent, chronic phase (LEUKEMIA, MYELOID, CHRONIC PHASE) lasting up to 7 years, to an advanced phase composed of an accelerated phase (LEUKEMIA, MYELOID, ACCELERATED PHASE) and BLAST CRISIS.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Breuer, W | 1 |
Epsztejn, S | 1 |
Millgram, P | 1 |
Cabantchik, IZ | 1 |
Goldenberg, H | 1 |
Dodel, B | 1 |
Seidl, D | 1 |
2 other studies available for pentetic acid and Leukemia, Myelogenous, Chronic, BCR-ABL Positive
Article | Year |
---|---|
Transport of iron and other transition metals into cells as revealed by a fluorescent probe.
Topics: Biological Transport; Calcimycin; Cations; Cations, Divalent; Cell Line; Fluoresceins; Fluorescent D | 1995 |
Plasma membrane Fe2-transferrin reductase and iron uptake in K562 cells are not directly related.
Topics: 2,2'-Dipyridyl; Cell Line; Cell Membrane; Endocytosis; Humans; Iron; Kinetics; Leukemia, Myelogenous | 1990 |